Literature DB >> 26869475

Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012.

Anders Nøhr1, Simon Andreasen2,3,4, Marianne Hamilton Therkildsen5, Preben Homøe3,4.   

Abstract

The purpose was to assess degree of permanent facial nerve dysfunction after surgery for recurrent pleomorphic adenoma (RPA) of the parotid gland, including variables that might influence re-operation outcomes. Nationwide retrospective longitudinal cohort study including a questionnaire survey of patients undergoing surgery for RPA. Of 219 living patients, 198 (92 %) responded and 127 (63 %) reported no facial dysfunction. Statistically significant associations were found between number of surgeries and permanent facial nerve dysfunction of all degrees (OR 1.43, 95 % CI 1.16-1.78, p = 0.001). A not significant tendency for females to be associated with worse outcome was found (p = 0.073). Risks of different degrees of paresis after the second-fourth surgeries were found (OR 1.86-2.19, p < 0.05). Our study demonstrates a significant correlation between number of surgeries for RPA of the parotid and severity of facial nerve paresis. This is important when informing and planning treatment of these patients.

Entities:  

Keywords:  Facial nerve paresis; Morbidity; Pleomorphic adenoma; Recurrence; Surgery

Mesh:

Year:  2016        PMID: 26869475     DOI: 10.1007/s00405-016-3921-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  16 in total

1.  Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors.

Authors:  Peter Zbären; Edouard Stauffer
Journal:  Head Neck       Date:  2007-08       Impact factor: 3.147

2.  [Quality of life survey on patients with peripheral facial paralysis by using Chinese version of the FaCE scale].

Authors:  Yang Li; Hong Jiang; Ke Wang; Guo-dong Feng; Xiu-yong Ding; Yang Zha; Ting-ting Cui; Zhi-qiang Gao
Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi       Date:  2013-01

3.  Variables related to recurrence of pleomorphic adenomas: outcome of parotid surgery in 182 cases.

Authors:  Magdy Amin Riad; Hussein Abdel-Rahman; Waleed F Ezzat; Ahmad Adly; Ossama Dessouky; Mohamed Shehata
Journal:  Laryngoscope       Date:  2011-06-10       Impact factor: 3.325

4.  Recurrent pleomorphic adenoma of the parotid gland.

Authors:  Peter Zbären; Isabelle Tschumi; Michel Nuyens; Edouard Stauffer
Journal:  Am J Surg       Date:  2005-02       Impact factor: 2.565

5.  Facial nerve grading systems.

Authors:  J W House
Journal:  Laryngoscope       Date:  1983-08       Impact factor: 3.325

6.  Validation of a patient-graded instrument for facial nerve paralysis: the FaCE scale.

Authors:  J B Kahn; R E Gliklich; K P Boyev; M G Stewart; R B Metson; M J McKenna
Journal:  Laryngoscope       Date:  2001-03       Impact factor: 3.325

7.  An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland.

Authors:  A Renehan; E N Gleave; M McGurk
Journal:  Am J Surg       Date:  1996-12       Impact factor: 2.565

8.  Facial nerve morbidity following parotid surgery for benign disease: the Cleveland Clinic Foundation experience.

Authors:  M E Mehle; D H Kraus; B G Wood; M S Benninger; I Eliachar; H L Levine; H M Tucker; P Lavertu
Journal:  Laryngoscope       Date:  1993-04       Impact factor: 3.325

9.  Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.

Authors:  Eberhard Stennert; Claus Wittekindt; Jens Peter Klussmann; Georg Arnold; Orlando Guntinas-Lichius
Journal:  Laryngoscope       Date:  2004-01       Impact factor: 3.325

10.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

View more
  2 in total

1.  Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.

Authors:  Pawel Sowa; Maciej Misiolek; Maciej Zielinski; Bogdan Mazur; Monika Adamczyk-Sowa
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

2.  Recurrent Parotid Pleomorphic Adenomas: Our Clinical Experience.

Authors:  Özgür Kümüş; Ahmet Ömer İkiz; Sülen Sarıoğlu; Taner Kemal Erdağ
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.